• Users Online: 357
  • Print this page
  • Email this page
Year : 2017  |  Volume : 11  |  Issue : 4  |  Page : 198-200

Renal transplantation in a patient with alport syndrome and cardiac dysfunction: Role of levosimendan

Department of Anaesthesia, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India

Correspondence Address:
Kusuma Ramachandra Halemani
A3 “SAYANA”, “SUHA” Residency, Poonthi Road, Kumarapura, Trivandrum - 695 011, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijot.ijot_50_17

Rights and Permissions

Anesthetic management in patients with end-stage renal disease and cardiac dysfunction coming for renal transplant is very challenging since the maintenance of adequate cardiac output is essential for good graft function. Levosimendan is an inodilator that increases cardiac output without increasing cardiac workload. Hence, it is the drug of choice in patients with ischemic heart disease and congestive cardiac failure. We present successful perioperative management of a renal transplant recipient with left ventricular dysfunction using levosimendan for maintenance of stable hemodynamics. Levosimendan, an inodilator, can be safely used in patients with cardiac dysfunction coming for renal transplantation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded128    
    Comments [Add]    

Recommend this journal